Alnylam Pharmaceuticals
ALNY
#568
Rank
โ‚น3.999 T
Marketcap
โ‚น29,972
Share price
0.26%
Change (1 day)
44.88%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company